| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |